KJIM :: Korean Journal of Internal Medicine

Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma

Jing Yang, Limin Chai, Junting Jia, Liping Su, Zhiying Hao

Not all bad: Drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival

Wen Wei, Yajie Zhu, Jianning Tang, Chuan Xu, Jiman Li, Shuya He, Zhihui Zhang, Ping Wu, Lei Luo, Qin Guo, Fang Li, Yuanrong Ren, Sisi Yu, Renqin Li, Li Li

Age-Related Disease Risks in Younger versus Older B-Cell Non-Hodgkin's Lymphoma Survivors

Krista Ocier, Sarah Abdelaziz, Seungmin Kim, Kerry Rowe, John Snyder, Vikrant G. Deshmukh, Michael Newman, Alison Fraser, Ken R. Smith, Christina A. Porucznik, Kimberley Shoaf, Joseph B. Stanford, Catherine J. Lee, Mia Hashibe

Cancer Epidemiology, Biomarkers & Prevention.2021; 30(12): 2268. CrossRef

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies

Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye, Michael Boyle

Clinical Microbiology Reviews.2020;[Epub] CrossRef

Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy

Cong Li, Fangxiao Lu, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

Marta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo, Patricia Karina Aruj, Silvia Attorri, Enrique Bari

Clinical Infectious Diseases.2019; 68(9): 1482. CrossRef

Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma

Wei Ping Liu, Xiao Pei Wang, Wen Zheng, Yan Xie, Mei Feng Tu, Ning Jing Lin, Ling Yan Ping, Zhi Tao Ying, Chen Zhang, Li Juan Deng, Ning Ding, Xiao Gan Wang, Yu Qin Song, Jun Zhu

Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival

Kimberly Keefer, Regis Bender, Jason Liao, Jeffrey Sivik, Andry Van de Louw

Annals of Hematology.2018; 97(12): 2373. CrossRef

Immunochemotherapeutic increase of peripheral absolute monocyte count predicts interstitial pneumonia in lymphoma patients

Mingxiao Lang, Jingwei Yu, Xianhuo Wang, Zheng Song, Lanfang Li, Lihua Qiu, Huilai Zhang

Hematological Oncology.2018; 36(5): 779. CrossRef

Drug-Induced Interstitial Lung Disease: A Systematic Review

Sarah Skeoch, Nicholas Weatherley, Andrew Swift, Alexander Oldroyd, Christopher Johns, Conal Hayton, Alessandro Giollo, James Wild, John Waterton, Maya Buch, Kim Linton, Ian Bruce, Colm Leonard, Stephen Bianchi, Nazia Chaudhuri

Journal of Clinical Medicine.2018; 7(10): 356. CrossRef

Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors

Ioannis Kyriakidis, Athanasios Tragiannidis, Ilse Zündorf, Andreas H. Groll

TrkA is a binding partner of NPM‐ALK that promotes the survival of ALK+ T‐cell lymphoma

Wenyu Shi, Suraj Konnath George, Bhawana George, Choladda V. Curry, Albina Murzabdillaeva, Serhan Alkan, Hesham M. Amin

Doxorubicin Induces Inflammatory Modulation and Metabolic Dysregulation in Diabetic Skeletal Muscle

Rashmi Supriya, Bjorn T. Tam, Xiao M. Pei, Christopher W. Lai, Lawrence W. Chan, Benjamin Y. Yung, Parco M. Siu

Pneumocystispneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy

Se Yoon Park, Mi Young Kim, Won Jin Choi, Dok Hyun Yoon, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Cheolwon Suh, Jun Hee Woo, Sung-Han Kim

Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab

Giselle Salmasi, Michael Li, Vithika Sivabalasundaram, Tony Panzarella, Richard Tsang, Vishal Kukreti, Michael Crump, John Kuruvilla

Fatal rituximab‐associated lung injury syndrome in a patient treated with rituximab for recurrence of post‐transplant nephrotic syndrome

Ryszard Grenda, Wioletta Jarmużek, Jacek Rubik, Marek Migdał, Maciej Pronicki

Pneumonitis following immunochemotherapy with rituximab: a new well-designed retrospective study to better assess the risks

Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis

Xuqin Jiang, Xiaodong Mei, Di Feng, Xiaojing Wang, Herbert B. Tanowitz

Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014

L. Cooley, C. Dendle, J. Wolf, B. W. Teh, S. C. Chen, C. Boutlis, K. A. Thursky

Internal Medicine Journal.2014; 44(12b): 1350. CrossRef

Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy

Tark Kim, Sang-Ho Choi, Sung-Han Kim, Jin-Yong Jeong, Jun Hee Woo, Yang Soo Kim, Heungsup Sung, Mi-Na Kim, Dok Hyun Yoon, Cheolwon Suh, Sang-Oh Lee

Non-infectious pulmonary toxicity of rituximab: a systematic review

A. V. Hadjinicolaou, M. K. Nisar, H. Parfrey, E. R. Chilvers, A. J. K. Ostor

Pulmonary toxicities from targeted therapies: a review